The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Is BPC 157 Legal? Understanding Its Status and Implications The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA's Legislative Request on Rx and Compounded Drug Advertising Coalition for Healthcare Communication FDA's Overreach on Compounded Peptides